Hederacoside C
CAS No. 14216-03-6
Hederacoside C( Kalopanaxsaponin B | Hederacoside C | Hederoside H1 )
Catalog No. M17289 CAS No. 14216-03-6
Hederacoside C is expectorant for Cold and cough relief, Bronchitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 75 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 25MG | 292 | In Stock |
|
| 50MG | 406 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHederacoside C
-
NoteResearch use only, not for human use.
-
Brief DescriptionHederacoside C is expectorant for Cold and cough relief, Bronchitis.
-
DescriptionMutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
-
In VitroWestern Blot Analysis Cell Line: Caco-2 Concentration:0.1, 1, 10 μM Incubation Time:1 h Result:Reduced the expression of p-p65/p65, p-JNK, p-ERK, and p-p38.RT-PCR Cell Line:RAW 264.7 Concentration:5, 10, 50 μg/mL Incubation Time:1 h Result:Reduced the expressions of IL-1β, IL-6, TNF-α, and IL-10.
-
In VivoAnimal Model:TNBS-induced colitis in rat Dosage:0.625, 1.25, 2.5 mg/kg Administration:i.p.Result:Decreased the levels of inflammatory cytokines, including TNF-α, IL-6, IL-1β, CXCL-1, CXCL-2, and CXCL-5.Reduced cell apoptosis in TNBS-induced colitis.Reduced Bax/Bcl-2 ratio, cleaved caspase 3, and p53 protein levels in a dose-dependent manner.
-
SynonymsKalopanaxsaponin B | Hederacoside C | Hederoside H1
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number14216-03-6
-
Formula Weight1221.39
-
Molecular FormulaC59H96O26
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (81.87 mM)
-
SMILES[C@@H]1([C@@H](OC[C@@H]([C@@H]1O)O)O[C@@H]1[C@]([C@H]2[C@@]([C@@H]3[C@]([C@]4(C(=CC3)[C@H]3[C@@](CC4)(CCC(C3)(C)C)C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO[C@H]3[C@@H]([C@H]([C@H](O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)[C@H](O3)CO)O)O)O)O)O)C)(CC2)C)(CC1)C)(CO)C)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O
-
Chemical NameOlean-12-en-28-oic acid, 3- ((2-O-(6-deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl)oxy)-23-hydroxy-, O-6-deoxy-alpha-L-mannopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranosyl ester, (3beta,4alpha)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim JM, et al. Xenobiotica. 2013 Nov;43(11):985-92.;
molnova catalog
related products
-
JNJ 39220675
JNJ 39220675 is potent and selective, brain penetrant H3 antagonist with Ki of 1.4 nM, pA2 of 9.42 for hH3.
-
GSK189254A
GSK189254A is a potent and specific histamine H3 receptor antagonist (pKi values: 9.59-9.90 and 8.51-9.17 for human and rat H3).
-
Bicyclol
Bicyclol(SY 801) is an anti-hepatitis drug. Oral administration of bicyclol normalizes the elevated serum transaminases (ALT, AST) by 50% in chronic viral hepatitis B and C, and also has a certain level of inhibiting HBV and HCV replication.
Cart
sales@molnova.com